๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers Clinical trials China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Multimodal Tongue-Pulse Information Fusion for Syndrome Diagnosis and Cohort Study in Children With Asthma
NCT07383883Asthma
Shanghai Children's Medical Center
Observational
1,000
Shanghai
2026-02-01
Not yet open
SHR2554 as Maintenance Therapy in Patients With Peripheral T-cell Lymphoma
NCT07347288PTCL
The First Affiliated Hospital with Nanjing Medical University
Phase 2
30
Nanjing
2026-02
Not yet open
A Phase III Study to Evaluate the Efficacy and Safety of MDR-001 in Adult Participants With Overweight or Obesity (MOBILE๏ผ‰
NCT07274137Overweight or Obesity
MindRank AI Ltd
Phase 3
738
Beijing, Changchun, Changde, Changsha, Datong, Dongyang, Ganzhou, Hefei
2026-02
Recruiting
Safety and Efficacy of the RENATUSยฎ Transcatheter Aortic Valve System for the Treatment of Severe Aortic Stenosis
NCT07414342Severe Aortic Stenosis
Beijing Balance Medical Technology Co., Ltd
Not applicable
800
Beijing
2026-02
Recruiting
A Multicenter Clinical Study of Combined Therapy for Unresectable Hepatocellular Carcinoma
NCT07482059Unresectable Hepatocellular Carcinoma
West China Hospital
Phase 1/2
33
Chengdu
2026-02
Not yet open
Safety and Efficacy Evaluation of LC-K76 in Patients With Metastatic Hormone-Sensitive Prostate Cancer
NCT07389174mHSPC, mHNPC, Prostate Cancer Adenocarcinoma
Shanghai Changzheng Hospital
Phase EARLY_PHASE1
40
Shanghai
2026-02
Not yet open
A Phase III Study of GS101 Injection to Dupixentยฎ
NCT07386743Atopic Dermatitis (AD)
Jiangsu Genscend Biopharmaceutical Co., Ltd
Phase 3
572
Shenyang
2026-02
Recruiting
Study of CD19 CAR-T Therapy for Refractory SLE
NCT07403097Systemic Lupus Erythematosus
Chongqing Precision Biotech Co., Ltd
Phase 1
18
Chongqing
2026-02
Recruiting
Exploratory Clinical Study of cCTL in Combination With Immunotherapy for Advanced Gynecologic Malignancies
NCT07434284Advanced Gynecological Cancers
Obstetrics & Gynecology Hospital of Fudan University
Phase EARLY_PHASE1
20
Shanghai
2026-02
Not yet open
Scipibaimab Combined With Tislelizumab in Patients With First-Line Treatment-Failed Recurrent/Metastatic Nasopharyngeal Carcinoma
NCT07388758Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University
Phase 2
37
Guangzhou
2026-02
Not yet open
NECTAR Study: Neoadjuvant Toripalimab + 9MW2821 for Local UTUC
NCT07412171Upper Tract Urothelial Carcinoma
Peking University Third Hospital
Phase 2
40
Beijing
2026-02
Not yet open
Study of Ripertamab in Children With Frequent Relapses or Steroid-Dependent Nephrotic Syndrome
NCT07388810FRNS/SDNS, Ripertamab
Mao Jianhua
Not applicable
312
Hangzhou
2026-02
Not yet open
Golidocitinib for Refractory Immune-related Hematologic Toxicities of Advanced Lung Cancer
NCT07303881IrAE, Hematologic Disorder, Lung Cancer (Locally Advanced or Metastatic)
The First Affiliated Hospital of Guangzhou Medical University
Phase 2
16
Guangzhou
2026-02
Not yet open
Safety and Preliminary Efficacy Evaluation of LC-K76 Plus Anti-PD-1 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
NCT07389187mCRPC
Shanghai Changzheng Hospital
Phase EARLY_PHASE1
10
Shanghai
2026-02
Not yet open
Neoadjuvant Becotatug Vedotin Plus Pucotenlimab and Cisplatin for Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT07393477Head and Neck Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma HNSCC
Sir Run Run Shaw Hospital
Phase 2
30
Hangzhou
2026-02
Not yet open
Camouflaged WeChat-based Intervention for Abused Women
NCT07405528Domestic Violence, Mental Health Wellness 1
The University of Hong Kong
Not applicable
86
Hong Kong
2026-02
Not yet open
Simple Swallowing Training Program on Older Individuals in the Community
NCT07373028Dysphagia
Zeng Changhao
Not applicable
474
Suzhou, Zhenzhou
2026-02
Recruiting
Response-Based Local Therapy for Regionally Advanced Breast Cancer
NCT07376538Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
157
Beijing
2026-02
Not yet open
IMM0306 in Combination With Lenalidomide vs Placebo in Combination With Lenalidomide in Patients With Relapsed/Refractory Follicular Lymphoma
NCT07355283Relapsed/Refractory Follicular Lymphoma
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Phase 3
198
Beijing
2026-02
Recruiting
Clinical Study of Oncolytic Vaccinia VIrus Delivering Targeted CD19 in Vivo CAR-T/M Therapy for Refractory/Relapsed B-cell Lymphoma
NCT07398963Refractory/Relapsed B-cell Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1
48
Hangzhou
2026-02
Not yet open
Electrocautery Resection Combined With HITHOC for Thymic Epithelial Tumors With Pleural Metastasis
NCT07328074Thymic Epithelial Tumor, Thymoma, Thymic Carcinoma, Pleural Metastasis
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Observational
70
Shanghai
2026-02
Not yet open
Clinical Study of Anti-CLL1-CD33-NKG2D Bicephali CAR-T for Relapsed/Refractory Acute Myeloid Leukemia
NCT07370064AML (Acute Myeloid Leukemia)
Xuzhou Medical University
Phase 1/2
20
Xuzhou
2026-01-31
Not yet open
Efficacy and Safety of Xeligekimab in the Treatment of Non-Radiographic Axial Spondyloarthritis
NCT07339566Nr-axial Spondyloarthritis, Non-Radiographical Axial Spondyloarthritis
Lingli Dong
Phase 2/3
40
Wuhan
2026-01-31
Recruiting
Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AA
NCT07400341MDS (Myelodysplastic Syndrome), Aplastic Anemia (AA)
The First Affiliated Hospital of Soochow University
Phase 2
66
Suzhou
2026-01-31
Not yet open
Compound Granules of Hedyotis Diffusa for Chronic Atrophic Gastritis
NCT07391800Chronic Atrophic Gastritis With Hyperplasia (Diagnosis)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
20
Shanghai
2026-01-31
Active, closed
A Prospective, Randomized, Blind, Controlled Multicenter Clinical Study Comparing the Effectiveness of Preventive Ventricular Arrhythmia Ablation on the Prognosis After Left Ventricular Assist Device (LVAD) Surgery.
NCT07589738CHF - Congestive Heart Failure
The First Affiliated Hospital of Anhui Medical University
Not applicable
90
Hefei
2026-01-31
Not yet open
A Phase I/II Study to Evaluate XNW34017 in Patients With Advanced or Metastatic Solid Tumor
NCT07327294Advanced Solid Tumors
Evopoint Biosciences Inc.
Phase 1/2
150
Guangzhou
2026-01-31
Not yet open
AI-Generated Video Feedback to Improve Technical Skills in Coronary Artery Bypass Grafting
NCT07400172Cardiac, Surgery (Cardiac), Education, Artificial Intelligence (AI)
China National Center for Cardiovascular Diseases
Not applicable
100
Beijing
2026-01-31
Recruiting
Study of MCLA-129 in Combination With Ensartinib in Patients With Advanced Solid Tumors.
NCT07448116Solid Advanced Tumor
Betta Pharmaceuticals Co., Ltd.
Phase 1/2
164
Beijing
2026-01-31
Not yet open
Integrated Clinical-molecular Risk Stratification to Early Recurrence in Colorectal Liver Metastases
NCT07391007Colorectal Liver Metastases
Fudan University
Observational
200
Shanghai
2026-01-31
Not yet open
A Phase II Trial of a Recombinant Human Anti-Rabies Virus Monoclonal Antibody
NCT07445815Rabies (Healthy Volunteers)
Lanzhou Institute of Biological Products Co., Ltd
Phase 2
200
Lanzhou
2026-01-31
Recruiting
Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study
NCT06794073Carcinoma, Hepatocellular, Neoplasms, Glandular and Epithelial, Adenocarcinoma, Digestive System Neoplasms
Shanghai Zhongshan Hospital
Not applicable
17
Shanghai
2026-01-31
Not yet open
Development and Validation of a Cardiac Magnetic Resonance-Based Multimodal Deep Learning Model for Long-Term Outcome Prediction in ST-Segment Elevation Myocardial Infarction
NCT07277400ST Elevation (STEMI) Myocardial Infarction
Qian geng
Observational
800
Beijing
2026-01-31
Active, closed
A Study of Remternetug (LY3372993) in Healthy Chinese Participants
NCT07346495Healthy
Eli Lilly and Company
Phase 1
24
Beijing, Xuhui District
2026-01-31
Recruiting
Iruplinalkib in ALK-Positive Advanced Lung Adenocarcinoma After Lorlatinib
NCT07374614Non-Small Cell Lung Cancer, ALK, Iruplinalkib, Lorlatinib
Peking University Shenzhen Hospital
Observational
20
Shenzhen
2026-01-31
Not yet open
An Observational Study on Gastric Cancer in High-risk Individuals
NCT07438418Gastric Adenocarcinoma
Fudan University
Observational
3,000
Tongling
2026-01-31
Not yet open
The Effect of Speaking Valve on Physiological Parameters With Wearable Devices
NCT07422350Tracheostomy Decannulation
Jingyi Ge
Observational
120
Beijing
2026-01-31
Active, closed
Ex Vivo Perfusion of Gene-Edited Porcine Livers in Patients With Severe Hepatic Failure
NCT07519005Hepatic Failure
Xijing Hospital
Phase EARLY_PHASE1
1
Xi'an
2026-01-31
Not yet open
A Phase Ib/II Study to Evaluate HLX43 Combined With HLX07 or Serplulimab in Patients With Advanced or Metastatic Colorectal Cancer
NCT07358585Colon Cancer Adenocarcinoma
Shanghai Henlius Biotech
Phase 1/2
126
Guangzhou
2026-01-31
Recruiting
Eye Tracking Study on Eye Movement Function and Visual Attention Patterns in Patients With Thyroid-Associated Ophthalmopathy
NCT07381413Thyroid Associated Ophthalmopathies, Eye Tracking
Shanghai Changzheng Hospital
Observational
100
Shanghai
2026-01-31
Recruiting
Zorifertinib With Osimertinib for NSCLC With Meningeal Progression
NCT07361705Patients With Advanced Non-small Cell Lung Cancer With Meningeal Progression After Osimertinib Treatment
Alpha Biopharma (Jiangsu) Co., Ltd.
Phase 1
42
Beijing, Shengyang, Guangzhou, Henan, Shanxi
2026-01-31
Not yet open
Exploration of Treatment Strategies After Concurrent Chemoradiotherapy for LS-SCLC Guided by MRD
NCT07357532Small Cell Lung Carcinoma
Peking University Cancer Hospital & Institute
Phase 2
44
Beijing
2026-01-31
Not yet open
A Phase I Platform Study of Target-Based Screened CAR-Macrophages for the Treatment of Advanced Malignant Tumors
NCT07409766Advanced Malignant Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase EARLY_PHASE1
20
Beijing
2026-01-31
Recruiting
Basilar Artery Occlusion Chinese Endovascular Registry in Patients With Large-Core Infarct
NCT07345702Basilar Artery Occlusion, Ischemic Stroke, Large Core Infarct
Xuanwu Hospital, Beijing
Observational
518
Beijing
2026-01-31
Not yet open
Efficacy and Safety of Hyperbaric Oxygen Therapy in Improving Nab-paclitaxel-Induced Peripheral Neuropathy
NCT07410169Breast Cancer, CIPN - Chemotherapy-Induced Peripheral Neuropathy, Paclitaxel-induced Peripheral Neuropathy
Guangdong Provincial People's Hospital
Phase 2/3
160
Guangzhou
2026-01-31
Not yet open
Topefilgrastim Injection in the Treatment of High-Risk Pregnant Patients With Preeclampsia
NCT07384936Preeclampsia
Fang Wang
Not applicable
100
Lanzhou
2026-01-31
Recruiting
Assessment of Food Intake Using Both 3D Scanning Method and a Photographic Method
NCT07371559Data Collection
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
Observational
200
Shenzhen
2026-01-31
Recruiting
Structured Active Follow-up in Postoperative Management of Thyroid
NCT07589660Patients After Thyroid Surgery
Yu Feng
Not applicable
244
Chengdu
2026-01-31
Not yet open
The Effectiveness and Safety of Artificial Intelligence(AI)-Assisted Medical Treatment Decision Support System Compared to Conventional Care in HFrEF Patients
NCT07380555Heart Failure With Reduced Ejection Fraction (HF-rEF)
Shanghai Zhongshan Hospital
Not applicable
1,200
Shanghai
2026-01-30
Recruiting
Intrauterine Injection of Type III Collage in FST of EC/AEH
NCT07377734Atypical Endometrial Hyperplasia, Endometrial Cancer
Wang Jianliu
Phase 2
30
Beijing
2026-01-30
Not yet open
Isa-VRD in TIE HRMM
NCT07334535Multiple Myeloma
Peking Union Medical College Hospital
Phase 4
117
Beijing
2026-01-30
Not yet open
Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast Cancer
NCT07419880Triple -Negative Breast Cancer
Fudan University
Phase 2
46
Shanghai
2026-01-30
Not yet open
Preliminary Evaluation of Clinical Application of SPECT Imaging Targeting GPC3
NCT07353333HCC, SPECT-CT
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
6
Wuhan
2026-01-30
Recruiting
Jiedu Huayu Oral Prescription in the Treatment of Intracranial Hemorrhage Associated With Cerebral Amyloid Angiopathy
NCT07250035Cerebral Amyloid Angiopathy
Beijing Tiantan Hospital
Phase 3
436
Beijing
2026-01-30
Not yet open
Motor Development Assessment and Support for Children With Neurodevelopmental Disorders
NCT07323004Neurodevelopmental Disorders
Aiyoudong Children and Youth Sports Health Research Institute
Not applicable
100
Beijing
2026-01-30
Recruiting
Frequency of Electrical Acupoint Stimulation on Hypotension in TAVR Patients
NCT07365345Transcatheter Aortic Valve Replacement (TAVR), Hemodynamic Stability, Anesthesia Induction, Electro-acupuncture
Air Force Military Medical University, China
Not applicable
150
Xi'an
2026-01-30
Recruiting
SKB500 Combinations in Patients With Small Cell Lung Cancer
NCT07296809Small Cell Lung Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2
80
Guangzhou
2026-01-30
Recruiting
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
NCT07288177Non-small Cell Lung Cancer (NSCLC)
Genmab
Phase 2
240
Shanghai, Beijing, Tianjin, Zhangjiakou, Zhengzhou
2026-01-30
Not yet open
Integrated Study on Gut Microbiota, Immune Indicators, and Trace Elements in Children With Respiratory Tract Infections
NCT07378852Respiratory
Min-Tze LIONG
Observational
120
Lanzhou
2026-01-30
Recruiting
Prognosis of Primary Aldosteronism: A Prospective Cohort Study
NCT07378176Primary Aldosteronism
Xinjiang Medical University
Observational
5,000
Chengdu, รœrรผmqi
2026-01-30
Not yet open
Drug Sensitivity Testing-Based Tumor Organoids to Guide Adjuvant Therapy After Hepatectomy for Primary Liver Cancer
NCT07363356Hepatocellular Carcinoma Resectable
Eastern Hepatobiliary Surgery Hospital
Phase 2
56
Shanghai
2026-01-30
Recruiting
A Study of GC203 TIL in Advanced Solid Tumors (NF)
NCT07256756Solid Tumors, Adult
Shanghai Juncell Therapeutics
Phase 1
8
Shenzhen
2026-01-30
Not yet open
A Phase IIIc Clinical Study to Evaluate the Long-term Treatment of Hydronidone Capsules for Liver Fibrosis in Patients With Chronic Hepatitis B.
NCT07412236Liver Fibrosis, Liver Fibrosis in Chronic Hepatitis B
Beijing Continent Pharmaceutical Co, Ltd.
Phase 3
1,208
Shanghai
2026-01-30
Not yet open
Efficacy and Safety of Pregabalin/Tizanidine vs. Pregabalin in Patients With Fibromyalgia
NCT07382921Fibromyalgia, Pregabalin, Pain
Beijing Tiantan Hospital
Not applicable
164
Beijing
2026-01-30
Not yet open
Head to Head, Prospective, Open Label Multicenter Study on the Diagnostic Efficacy of GPC3 Targeted PET Imaging and Enhanced Magnetic Resonance Imaging for Hepatocellular Carcinoma
NCT07352345Malignant Neoplasm of Liver
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
150
Wuhan
2026-01-30
Recruiting
Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer
NCT07392541Advanced Biliary Tract Carcinoma
Tongji Hospital
Phase 1/2
29
Wuhan
2026-01-30
Not yet open
Safety and Efficacy of CLL1 CAR-T Followed by Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
NCT07342244AML, AML (Acute Myeloid Leukemia)
Donghua Zhang
Not applicable
18
Wuhan
2026-01-30
Not yet open
the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines
NCT07338851Polio, Measles, Rubella, Mumps
China National Biotec Group Company Limited
Observational
600
Suzhou, Handan, Yancheng, Hanzhong, Yuncheng, Mianyang
2026-01-30
Recruiting
Randomized Trial of Anticoagulation Plus Batroxobin for Acute Cerebral Venous Thrombosis
NCT07352358Cerebral Venous Thrombosis
Xuanwu Hospital, Beijing
Phase 4
72
Beijing
2026-01-30
Not yet open
A Study of the Pharmacokinetics and Safety of Anaprazole Sodium in Special Populations
NCT07345689Hepatic Insufficiency, Renal Insufficiency, Elderly
Xuanzhu Biopharmaceutical Co., Ltd.
Phase 4
60
Changchun
2026-01-30
Recruiting
Prospective Validation of an AI Model for Predicting Liver Metastasis in Colorectal Cancer
NCT07392567Colorectal Cancer Liver Metastasis
Tongji Hospital
Observational
160
Wuhan
2026-01-30
Not yet open
A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases
NCT07212322Systemic Lupus Erythematosus, Idiopahic Inflammatory Myopathies, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Sjรถgren's Syndrome
Institute of Hematology & Blood Diseases Hospital, China
Not applicable
24
Tianjin
2026-01-30
Not yet open
Robot/Laparoscopic-Assisted Transanal Transection Duhamel Versus Modified Soave Pull-Through for TCA
NCT07343622Total Colonic Aganglionosis, Hirschsprung Disease, Duhamel, Soave
Zunyi Medical College
Not applicable
50
Zunyi
2026-01-30
Recruiting
Preop US-Guided Nerve Blocks for Pain & Recovery After Ankle Arthroscopy
NCT07470021Ankle Ligament Injury๏ผŒChronic Ankle Instability๏ผŒAnkle Arthroscopy
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
70
Hangzhou
2026-01-30
Recruiting
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
NCT07227298Advanced/Metastatic Non-Small Cell Lung Cancer, Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Cancer
Pfizer
Phase 1/2
162
Beijing, Wuhan, Nanjing, Shanghai, Taizhou
2026-01-30
Not yet open
Zillion: Zanubrutinib Combined With Chemotherapy for Newly Diagnosed CNS Lymphoma
NCT07405255Central Nervous System Lymphoma
Ruijin Hospital
Phase 2
19
Shanghai
2026-01-30
Not yet open
Efficacy and Safety of Methylprednisolone After Flow-Diverter Stent Implantation in Unruptured Intracranial Aneurysms
NCT07353749Unruptured Intracranial Aneurysms, Cerebrovascular Event, Hemorrhagic Stroke, Methylprednisolone
Duan Chuanzhi
Phase 4
864
Guangzhou
2026-01-30
Recruiting
A Phase 1/2 Study of GW5282 in Participants With Advanced Solid Tumors
NCT07328217Advanced Solid Tumors
Dizal Pharmaceuticals
Phase 1/2
203
Beijing
2026-01-29
Recruiting
HS-20093 in Patients With Advanced Gastric and Gastroesophageal Junction Adenocarcinoma
NCT07462923Advanced Gastric and Gastroesophageal Junction Adenocarcinoma
Hansoh BioMedical R&D Company
Phase 1
40
Shanghai
2026-01-29
Recruiting
Fulzerasib Sequential Sintilimab Plus Platinum-Doublet Neoadjuvant Therapy for Resectable KRAS G12C-Mutant NSCLC
NCT07492342Resectable NSCLC, KRAS G12C Mutation, Stage IB-IIIA NSCLC, Neoadjuvant Therapy
Jianxing He
Phase 2
30
Beijing, Guangzhou, Zhejiang
2026-01-29
Recruiting
Study of the Safety, Tolerability, Pharmacokinetics of VV913 Capsules in Chinese Healthy Participants
NCT07372703Healthy Volunteers
Vigonvita Life Sciences
Phase 1
56
Hefei
2026-01-29
Recruiting
In Vivo CAR-T for Refractory Graves' Disease
NCT07333677Graves' Disease
Shanghai Zhongshan Hospital
Phase EARLY_PHASE1
5
Shanghai
2026-01-29
Recruiting
A Study of MR001 in Patients With Locally Recurrent or Metastatic Advanced Triple-Negative Breast Cancer (TNBC)
NCT07208149Triple-Negative Breast Cancer (TNBC)
Shenzhen Majory Biotechnology Co., Ltd.
Phase 1/2
42
Beijing
2026-01-29
Recruiting
Platform Study of VSV-Based Recombinant Oncolytic Viruses for the Treatment of Advanced Malignant Tumors
NCT07656116Advanced Solid Tumor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1
27
Langfang
2026-01-29
Recruiting
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
NCT07227597Small Cell Lung Cancer Extensive Stage
Merck Sharp & Dohme LLC
Phase 1/2
170
Beijing, Fuzhou, Guangzhou, Jiangmen, Nanchang, Shanghai, Chengdu, Hangzhou
2026-01-29
Recruiting
Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
NCT07435038Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Advanced Solid Tumors
Betta Pharmaceuticals Co., Ltd.
Phase 1/2
120
Hangzhou
2026-01-29
Recruiting
A Phase II Clinical Trial to Evaluate the Efficacy and Safety of FXS5626 in Patients With NIU
NCT07552012Active Non-anterior, Non-infectious Uveitis
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Phase 2
40
Chongqing
2026-01-29
Recruiting
Exploratory Study of LP-98 for Injection in ART-Naive HIV-Infected Individuals
NCT07433387HIV
Shanxi Kangbao Biological Product Co., Ltd.
Phase 1/2
30
Tianjin
2026-01-29
Recruiting
Evaluate the Efficacy and Safety of HMI-115 in Women With Moderate to Severe Endometriosis-associated Pain
NCT07318688Endometriosis
Hope Medicine (Nanjing) Co., Ltd
Phase 3
540
Beijing, Nanning, Suzhu, Shanghai, Tianjin
2026-01-29
Recruiting
Exploring the Clinical Value of RT01-89Zr PET Imaging in Solid Tumors
NCT07505069Solid Tumors
Nanolattix Biotechnology Co., Ltd.
Phase EARLY_PHASE1
10
Wuxi
2026-01-29
Recruiting
A Clinical Study of Sintilimab Combined With Chemothrapy Versus Chemotherapy as Adjuvant Therapy for Gastric/Gastroesophageal Junction Adenocarcinoma
NCT07492615Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
Fudan University
Phase 2
276
Shanghai
2026-01-29
By invitation
Research on the Pathogenesis and Therapeutic Targets of Articular Cartilage Degeneration in Osteoarthritis
NCT07796607Osteoarthritis (OA)
Yunnan University of Chinese Medicine
Observational
30
Kunming
2026-01-29
Rows per page Showing 4001–4100 of 19052
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china?page=41

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.